Valuation: LivaNova PLC

Market Cap 4.27B 3.8B 3.52B 3.2B 6.05B 406B 6.14B 42.33B 16.6B 212B 16.04B 15.7B 675B P/E 2026 *
19.4x
P/E 2027 * 23.4x
Enterprise Value 4.35B 3.87B 3.58B 3.26B 6.15B 413B 6.25B 43.07B 16.89B 215B 16.32B 15.97B 687B EV / Sales 2026 *
2.86x
EV / Sales 2027 * 2.57x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 day-1.17%
1 week+1.56%
Current month+1.41%
1 month-1.18%
3 months-5.15%
6 months+19.34%
Current year+26.08%
1 week 75.13
Extreme 75.13
79.31
1 month 74.11
Extreme 74.11
80.19
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 29/02/2024
Director of Finance/CFO 56 30/10/2020
Investor Relations Contact - 31/07/2022
Director TitleAgeSince
Director/Board Member 69 18/10/2015
Chairman 74 08/06/2021
Director/Board Member 62 17/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
15/09/26 Free

General Counsel

6,291 0.0114%
10/09/26 Sell

Director

-3,500 0.0064%
04/09/26 Sell

Director

-2,300 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%+1.56%+43.96%+59.07% 4.27B
+0.20%+5.31%-17.82%+13.79% 181B
-0.73%+7.09%-0.31%+32.06% 116B
+0.49%+6.25%-20.20%+11.58% 113B
+3.83%+5.50%-44.18%-6.77% 79.83B
-0.14%+5.27%+6.74%+82.45% 65.06B
+2.79%+2.37%+15.93%+68.64% 54.35B
-1.04%+4.35%+3.50%-26.18% 52.23B
+2.41%+8.18%-12.08%+30.45% 44.15B
-1.90%+2.29%+29.72%+8.98% 32.47B
Average +0.55%+4.91%+0.53%+27.41% 74.29B
Weighted average by Cap. +0.61%+5.57%-9.39%+22.35%

Financials

2026 *2027 *
Net sales 1.52B 1.35B 1.25B 1.14B 2.15B 144B 2.19B 15.07B 5.91B 75.38B 5.71B 5.59B 240B 1.63B 1.45B 1.34B 1.22B 2.31B 155B 2.34B 16.14B 6.33B 80.74B 6.12B 5.99B 257B
Net income 226M 201M 186M 170M 320M 21.47B 325M 2.24B 879M 11.21B 849M 831M 35.72B 187M 166M 154M 140M 264M 17.74B 269M 1.85B 726M 9.26B 701M 687M 29.51B
Net Debt 75M 66.67M 61.79M 56.22M 106M 7.12B 108M 743M 291M 3.71B 281M 275M 11.84B -85M -75.56M -70.03M -63.72M -120M -8.07B -122M -842M -330M -4.21B -319M -312M -13.42B
Projected Income Statement - Annual - LivaNova PLC
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
16/10/26 US$77.58 -1.17% 773,999
15/10/26 US$78.50 +3.18% 737,976
14/10/26 US$76.08 -0.38% 464,614
13/10/26 US$76.37 -1.16% 561,290
12/10/26 US$77.27 +1.15% 1,029,634
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - LivaNova PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
77.58USD
Average target price
90.55USD
Spread / Average Target
+16.71%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LivaNova PLC
  1. Stock Market
  2. Stocks
  3. LIVN Stock